We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

960 hedge funds and large institutions have $45.5B invested in Thermo Fisher Scientific in 2014 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 346 increasing their positions, 368 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 111 | Existing positions closed: 58

36% more call options, than puts

Call options by funds: $195M | Put options by funds: $143M

5% more funds holding

Funds holding: 917960 (+43)

3% more capital invested

Capital invested by funds: $44.1B → $45.5B (+$1.41B)

0% more funds holding in top 10

Funds holding in top 10: 6767 (0)

0% less ownership

Funds ownership: 90.96%90.96% (-0%)

6% less repeat investments, than reductions

Existing positions increased: 346 | Existing positions reduced: 368

Holders
960
Holders Change
+43
Holders Change %
+4.69%
% of All Funds
25.6%
Holding in Top 10
67
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
1.79%
New
111
Increased
346
Reduced
368
Closed
58
Calls
$195M
Puts
$143M
Net Calls
+$51.9M
Net Calls Change
-$22.1M
Name Holding Trade Value Shares
Change
Change in
Stake
BE
576
Bonness Enterprises
District of Columbia
$1.57M
Creative Planning
577
Creative Planning
Kansas
$1.56M +$394K +3,238 +35%
HAIM
578
Hunter Associates Investment Management
Pennsylvania
$1.56M +$268K +2,205 +22%
FCFC
579
First Commonwealth Financial Corp
Pennsylvania
$1.49M -$82.4K -678 -5%
FA
580
FMA Advisory
Pennsylvania
$1.49M -$32.5K -267 -2%
FM
581
Family Management
New York
$1.49M +$176K +1,450 +14%
BA
582
Bridgewater Associates
Connecticut
$1.49M +$1.45M +11,899 New
FC
583
Forte Capital
New York
$1.48M -$63.8K -525 -4%
EWM
584
Evercore Wealth Management
New York
$1.47M +$9.12K +75 +0.6%
Harris Associates
585
Harris Associates
Illinois
$1.47M
CAM
586
Carret Asset Management
New York
$1.46M -$36.5K -300 -3%
CS
587
Credential Securities
$1.45M +$15.1K +124 +1%
MCWS
588
McKinley Carter Wealth Services
West Virginia
$1.45M +$170K +1,400 +14%
AT
589
Arden Trust
Delaware
$1.44M -$76.1K -626 -5%
CCS
590
Crosspoint Capital Strategies
California
$1.43M +$345K +2,836 +33%
GCP
591
GSA Capital Partners
United Kingdom
$1.41M -$162K -1,333 -11%
QIM
592
Quantitative Investment Management
Virginia
$1.39M +$1.35M +11,100 New
CIC
593
Canal Insurance Company
South Carolina
$1.37M
BBHC
594
Brown Brothers Harriman & Co
New York
$1.36M +$34.2K +281 +3%
SKK
595
Shepherd Kaplan Krochuk
Massachusetts
$1.36M -$24.3K -200 -2%
RMCM
596
Reynders McVeigh Capital Management
Massachusetts
$1.35M +$35.3K +290 +3%
Federated Hermes
597
Federated Hermes
Pennsylvania
$1.34M -$247K -2,031 -16%
QT
598
Quantbot Technologies
New York
$1.33M +$1.29M +10,645 New
BBI
599
Baxter Bros Inc
Connecticut
$1.33M +$3.89K +32 +0.3%
AC
600
Allstate Corporation
Illinois
$1.32M -$375K -3,081 -23%

TMO Hedge Fund Activity: Q4 2014 in Review

960 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2014, worth a combined $45.5B — up 3.2% from $44.1B a quarter earlier.

Buyers outnumbered sellers: 111 funds opened new TMO positions and 58 closed out — a net gain of 53 holders — while 346 added to existing stakes and 368 trimmed.

The largest buyer was Capital World Investors, adding an estimated $393M. The largest seller was Viking Global Investors, cutting an estimated $266M.

  • 960 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2014, up from 917 in Q3 2014.
  • Funds reported $45.5B of Thermo Fisher Scientific stock for Q4 2014, up 3.2% quarter-over-quarter.
  • 111 funds opened new Thermo Fisher Scientific positions in Q4 2014 and 58 closed out, a net change of +53 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2014 was Capital World Investors, an estimated $393M added.
  • The largest Thermo Fisher Scientific seller in Q4 2014 was Viking Global Investors, an estimated $266M sold.

Based on aggregated 13F filings for Q4 2014.